GLAND

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Gland Pharma Limited

Gland Pharma Limited, operating in the Healthcare sector as a Specialty & Generic Drug Manufacturer, engages in manufacturing and sale of injectable formulations. The company condu...

हिन्दी में

Gland Pharma Limited (GLAND), हेल्थकेयर सेक्टर में एक स्पेशलिटी और जेनेरिक ड्रग मैन्युफैक्चरर के रूप में, इंजेक्शन योग्य फॉर्मूलेशन के निर्माण और बिक्री में संलग्न है। कंपनी फार्मा...

₹3,079.1-2.27%1D
Previous trading day close · Data updates after market close
1W: +7.1%
1M: +4.0%
6M: +76.8%
1Y: +57.8%
65/100
AverageResearch Score
Market Cap
₹38.2K Cr
Large Cap
P/E Ratio
44.97
Premium
P/B Ratio
4.90
Premium
ROE
7.8%
Weak
ROCE
13.7%
Good
Debt / Equity
0.03
Low debt
Div. Yield
0.6%
Low yield
EV/EBITDA
28.39
Expensive
52W Low: ₹1,573.6Current: ₹3,079.152W High: ₹3,171
At 94% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
69/100
Growth
Revenue, EPS, profit growth
68/100
Valuation
PE, PB, EV/EBITDA vs sector
43/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
44.97(Premium)
Forward P/E
31.92(Premium)
P/B Ratio
4.90(Premium)
P/S Ratio
7.55(Expensive)
EV/EBITDA
28.39(Expensive)
Dividend Yield
0.6%
5Y CAGR
-6.6%(Moderate)
Revenue Growth
19.6%(Moderate)
Profitability
ROE
7.8%(Average)
ROCE
13.7%(Good)
ROA
6.4%(Average)
Net Margin
16.8%(High)
EBITDA Margin
30.0%
Financial Health
Debt to Equity
0.03(Low debt)
Current Ratio
4.33(Healthy)
Quick Ratio
3.26(Good)
Interest Coverage
50.55x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
62(Neutral)
RSI Exp (14)
65(Neutral)
MACD
50.700(Bullish)
MACD Signal
38.986
BB Position
95%(Upper band)
BB Width
10.19%(Normal)
ADX (14)
18.0(Sideways)
Williams %R
-27.9(Neutral)
MFI (14)
64(Neutral)
CCI (20)
214(Overbought)
Stoch %K
72(Neutral)
ATR (14)
89.19(Avg True Range)
OBV (M)
46.6(Positive)
1W OBV Chg
2.5%(Increasing)
Rel Volume
0.78x(Normal)
Volatility
32.4%(Moderate)
Max DD 1Y
-26.7%(Moderate)
Alpha (CAPM)
56.63%(Outperforming Nifty)
Return vs Nifty
64.1%(Beating Nifty)
EMA 200
2346.9
EMA 50
2827.8
SMA 200
2178.4
vs SMA 50
7.9%(Above SMA50)
vs SMA 200
41.4%(Above SMA200)
Volume
4.95L
Avg Vol 3M
6.4L
Shareholding Pattern
Promoter
51.8%
High confidence
FII
7.3%
DII / MF
33.4%
Strong MF interest
Share GLAND
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.